Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,304 papers from all fields of science
Search
Sign In
Create Free Account
C9orf72 wt Allele
Known as:
MGC23980
, RP11-27J8.2
, FTDALS
Expand
Human C9orf72 wild-type allele is located in the vicinity of 9p21.1 and is approximately 27 kb in length. This allele, which encodes uncharacterized…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
C9orf72 gene
Frontotemporal Dementia With Motor Neuron Disease
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Cognitive and Behavioral Symptoms in ALSFTD
S. Hsieh
,
Jashelle Caga
,
+11 authors
E. Mioshi
Journal of Geriatric Psychiatry and Neurology
2016
Corpus ID: 206570732
Brief screening tools that detect and differentiate patients with amyotrophic lateral sclerosis and frontotemporal dementia…
Expand
2016
2016
Genetic condition awaiting consideration - Amyotropic lateral sclerosis/frontotemporal dementia (FTDALS)
Human Fertilisation
,
Information Directorate
,
Web Team
2016
Corpus ID: 74542299
2014
2014
Body mass index delineates ALS from FTD: implications for metabolic health
Rebekah M. Ahmed
,
Rebekah M. Ahmed
,
+13 authors
Matthew C. Kiernan
Journal of Neurology
2014
Corpus ID: 25502178
Weight loss and catabolic changes are increasingly recognized as factors that influence outcomes in patients with amyotrophic…
Expand
2012
2012
Molecular evaluation of human Ubiquilin 2 gene PXX domain in familial frontotemporal dementia patients
I. Hernández
,
A. Espinosa
,
+6 authors
M. Boada
Journal of Neurology
2012
Corpus ID: 9806582
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) phenotypes appear in the same pedigrees [1] and can occur…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE